ST2: a new cardiovascular biomarker for the diagnosis and prognosis of heart failure

被引：0
|
作者：
Ramshev, K. Konstantin [1 ]
Ramsheva, Z. N. R. [2 ]
Grahliova, L. G. [2 ]
机构：
[1] Mil Med Acad Sofia, Intens Care, Sofia, Bulgaria
[2] Mil Med Acad Sofia, Dept Clin Lab & Immunol, Sofia, Bulgaria
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P264
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel
    Januzzi, James L.
    Pascual-Figal, Domingo
    Daniels, Lori B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (07): : 70B - 75B
  • [42] Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome
    Kopeva, K.
    Grakova, E., V
    Yakovlev, A., V
    Shilov, S. N.
    Yakovleva, N. F.
    Berezikova, E. N.
    Teplyakov, A. T.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2021, 20 : 132 - 132
  • [43] Serum Soluble ST2 as a Biomarker for Detecting Heart Failure with a Normal Ejection Fraction in Hypertensive Patients
    Wang, Yi-Chih
    Yu, Chih-Chieh
    Chiu, Fu-Chun
    Hwang, Juey-Jen
    Lai, Ling-Ping
    Tsai, Chia-Ti
    Lin, Jiunn-Lee
    CIRCULATION, 2011, 124 (21)
  • [44] Soluble ST2 as a Biomarker for Detecting Stable Heart Failure With a Normal Ejection Fraction in Hypertensive Patients
    Wang, Yi-Chih
    Yu, Chih-Chieh
    Chiu, Fu-Chun
    Tsai, Chia-Ti
    Lai, Ling-Ping
    Hwang, Juey-Jen
    Lin, Jiunn-Lee
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (03) : 163 - 168
  • [45] The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19
    Miftode, Radu-Stefan
    Petris, Antoniu Octavian
    Aursulesei, Viviana Onofrei
    Cianga, Corina
    Costache, Irina-Iuliana
    Mitu, Ovidiu
    Miftode, Ionela-Larisa
    Serban, Ionela-Lacramioara
    DIAGNOSTICS, 2021, 11 (02)
  • [46] Is soluble ST2 an useful biomarker for early diagnosis of coronary atherosclerosis?
    Ikeda, Shuntaro
    HYPERTENSION RESEARCH, 2025, 48 (02) : 839 - 841
  • [47] Characteristics of the interleukin family biomarker ST2 after heart transplantation
    Pascual Figal, D. A.
    Garrido, I. P.
    Blanco, R. M.
    Sanchez-Mas, J.
    Minguela, A.
    Gracia, R.
    Martinez, M. D.
    Ordonez, J.
    Bayes-Genis, A.
    Valdes, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 434 - 434
  • [48] Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation
    Galeone, Antonella
    Salem, Joe-Elie
    Lebreton, Guillaume
    Coutance, Guillaume
    Nguyen, Lee
    Hulot, Jean Sebastien
    Atassi, Fabrice
    Bega, Marco
    Leprince, Pascal
    Varnous, Shaida
    CLINICAL TRANSPLANTATION, 2022, 36 (05)
  • [49] Soluble ST2 - New Biomarker for acute Aortic Dissection?
    Eggebrecht, H.
    KARDIOLOGE, 2018, 12 (02): : 120 - 122
  • [50] ST2 pathophysiological profile in ambulatory heart failure patients
    Lupon, J.
    De Antonio, M.
    Galan, A.
    Zamora, E.
    Domingo, M.
    Urrutia, A.
    Cabanes, R.
    Altimir, S.
    Diez, C.
    Bayes-Genis, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 280 - 280
12345